Home / Intelligence / Briefs / COVID-19 Briefing Series: Impact of COVID-19 on Healthcare Market Research
The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. The social distancing measures that are critically important to address the pandemic present new challenges with patient recruitment for clinical trials, market research, and drug launches.
In this time of uncertainty, Trinity is assessing the impact on market research services including the ability of healthcare providers to participate in research.
In its latest brief, “Impact of COVID-19 on Healthcare Market Research,” Trinity provides insights for life science companies to help them navigate these uncertain times.
Publication Access Form
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Blog
RWE + PMR = Tethering Demand Forecasts to Reality
Reliable forecast models are a cornerstone of any successful commercialization plan. The inputs that drive those forecast models are critical. From 2020 through 2022: Only 1 in 10 products had performance aligned with forecasted expectations* Nearly 60% underperformed their forecast expectations More than 30% overperformed Forecast models often rely on healthcare professional (HCP)-reported behavioral data. […]
Read More
Webinars
RWE + PMR: A Powerful Approach to Demand Forecasting, Segmentation and More
May 14, 2024 | 1:00 – 1:45 PM ET
Predictive insights on stakeholder behavior are crucial, whether for demand assessments, segmentation, message testing, market mapping or ATUs—and the more rooted in reality these predictions are, the more confidence in the estimates and outputs. Join Trinity Insights experts Clive Mendonca, Managing Director & Head of Quantitative Insights and Amod Athavale, Director & Head of Integrated […]
Sign Up Now
Webinars
Learn From the Past – Launch Better Tomorrow
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, this webinar is a must-watch. Join us for an informative webinar as our experts dive into Trinity Life Sciences’ latest white paper, the Trinity Annual Drug Index—an evaluation of commercial performance over three years of 58 novel drugs approved in 2020. Hear from […]
Watch Now